Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen
Press Releases
Marengo Therapeutics  
March 3, 2025

Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen

Second licensed program created with Marengo's proprietary STAR precision T cell activation platform advances to IND-enabling phase

logo salamanca press

Salamanca Press

Local & Social